ICAP
ASPX

Independence Capital Asset Partners’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Independence Capital Asset Partners’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-28,499
Closed -$877K – 130
2014
Q1 		$877K Buy
+28,499
New +$766K 0.15% 68

Other funds holding ASPX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Independence Capital Asset Partners's ASPX Position: Q2 2014 in Review

Independence Capital Asset Partners sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2014, closing a stake of 28,499 shares — an estimated $877K sold.

Independence Capital Asset Partners first reported a position in ASPX in Q1 2014 and held it in 1 quarter. The position peaked at $877K in Q1 2014. 61 funds tracked by Wall St. Rank hold ASPX as of Q2 2014.

  • Independence Capital Asset Partners reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • Independence Capital Asset Partners sold 28,499 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2014, an estimated $877K.
  • Independence Capital Asset Partners first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 1 quarter.
  • Independence Capital Asset Partners's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $877K in Q1 2014.
  • 61 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2014.

Based on Independence Capital Asset Partners's 13F filing for Q2 2014, filed 14 Aug 2014.